Advanced Spine and Pain LLC
Advanced Spine and Pain LLC was paid $148K by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoADVANCED SPINE AND PAIN LLC
HAMMONTON, NJ 08037
HAMMONTON, NJ 08037
33aNPI1730359084assigned 03/03/2008
33bProvider typeSpeech-Language Pathologist
28Total paid$148K
24GClaims69,388
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Speech-Language Pathologist providers in New Jersey
Rank by total paid#19 of 105
Median peer was paid$30K
This provider vs. median4.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FREAS, DAMEAN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,944 | $12K | |
| 2019 | 2,099 | $7K | |
| 2020 | 9,503 | $4K | |
| 2021 | 15,554 | $25K | |
| 2022 | 15,159 | $58K | |
| 2023 | 14,890 | $24K | |
| 2024incomplete | 8,239 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 17,031 | 16,036 | $40K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21% | 15,781 | 14,192 | $31K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 15,637 | 14,196 | $24K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 12% | 2,572 | 2,284 | $18K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 6.4% | 1,826 | 1,689 | $9K |
| 99454 | 5.3% | 4,458 | 4,138 | $8K | |
| 99457 | 3.2% | 4,914 | 4,447 | $5K | |
| 95851 | 1.4% | 644 | 529 | $2K | |
| 97750 | 1.4% | 377 | 375 | $2K | |
| 96136 | 1.3% | 662 | 536 | $2K | |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.1% | 442 | 333 | $2K |
| G0443 | Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes | <1% | 412 | 381 | $1K |
19 more codes
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 540 | $1K |
| 99458 | <1% | 569 | $816.66 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 44 | $323.14 |
| 99408 | <1% | 119 | $227.80 | |
| 97814 | <1% | 135 | $154.36 | |
| 97813 | <1% | 142 | $144.84 | |
| 99484 | <1% | 1,239 | $118.72 | |
| 99442 | <1% | 253 | $117.92 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 53 | $72.01 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 547 | $55.68 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 25 | $32.30 |
| 96103 | <1% | 100 | $25.92 | |
| 98980 | <1% | 122 | $15.89 | |
| 98981 | <1% | 49 | $15.88 | |
| 96160 | <1% | 79 | $14.36 | |
| 99453 | <1% | 77 | $8.72 | |
| 99072 | 0% | 495 | $0.00 | |
| 99358 | Prolong nursin fac eval 15m | 0% | 27 | $0.00 |
| 96138 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFREAS, DAMEAN (CEO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.